Ymmunobio company logo with antibody symbol and text in blue and red on transparent background
Ymmunobio company logo with antibody symbol and text in white on transparent background
Contact

 /   News

Latest developments updates & insights

News

Latest news

Stay informed with the latest company announcements, research milestones & scientific publications from Ymmunobio.

All news

Ymmunobio banner with company logo and tagline Cancer Therapies for Tomorrow and Beyond

Ymmunobio Achieves Major Preclinical Milestone with YB-800 ADCs

Logo of Ymmunobio AG: red antibody as letter I, blue "mmunobio" text, on light gray; biotech in oncology and targeted therapies.

Ymmunobio & Paul-Scherrer Institute win Innosuisse grant to develop radiopharmaceutical with YB-800

Ymmunobio AG representatives in formal wear with award and nominee sign at oncology event, branded banner behind them.

We are very proud to announce our 3rd place achievement at the Prix Galien USA Awards!

Ymmunobio nominated for the 2024 Prix Galien USA Awards in the Best Startup category recognizing biotech innovation

Countdown to the Prix Galien Awards: Showcasing Science-Driven Innovation in NYC!

Ymmunobio and EVIIVE logos representing collaboration to develop liquid biopsy detecting NPTXR in cancer patients

Ymmunobio and EVIIVE announce collaboration to develop advanced liquid biopsy for detecting NPTXR in cancer patients

Ymmunobio banner with company logo and tagline Cancer Therapies for Tomorrow and Beyond

Ymmunobio is proud to announce our ASCO publication on YB-800